相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。Reinfection With Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) in Patients Undergoing Serial Laboratory Testing
Adnan Qureshi et al.
CLINICAL INFECTIOUS DISEASES (2022)
SARS-CoV-2 Neutralizing Antibodies for COVID-19 Prevention and Treatment
Dapeng Li et al.
ANNUAL REVIEW OF MEDICINE (2022)
Immunity to SARS-CoV-2 induced by infection or vaccination
Xaquin Castro Dopico et al.
JOURNAL OF INTERNAL MEDICINE (2022)
The germinal centre B cell response to SARS-CoV-2
Brian J. Laidlaw et al.
NATURE REVIEWS IMMUNOLOGY (2022)
A longitudinal study of SARS-CoV-2-infected patients reveals a high correlation between neutralizing antibodies and COVID-19 severity
Vincent Legros et al.
CELLULAR & MOLECULAR IMMUNOLOGY (2021)
Immunological memory to SARS-CoV-2 assessed for up to 8 months after infection
Jennifer M. Dan et al.
SCIENCE (2021)
IgA dominates the early neutralizing antibody response to SARS-CoV-2
Delphine Sterlin et al.
SCIENCE TRANSLATIONAL MEDICINE (2021)
Severe Reinfection With South African Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Variant 501Y.V2
Noemie Zucman et al.
CLINICAL INFECTIOUS DISEASES (2021)
Longitudinal Analysis of Human Memory T-Cell Response According to the Severity of Illness up to 8 Months After Severe Acute Respiratory Syndrome Coronavirus 2 Infection
Chang Kyung Kang et al.
JOURNAL OF INFECTIOUS DISEASES (2021)
Assessment of protection against reinfection with SARS-CoV-2 among 4 million PCR-tested individuals in Denmark in 2020: a population-level observational study
Christian Holm Hansen et al.
LANCET (2021)
Impact and effectiveness of mRNA BNT162b2 vaccine against SARS-CoV-2 infections and COVID-19 cases, hospitalisations, and deaths following a nationwide vaccination campaign in Israel: an observational study using national surveillance data
Eric J. Haas et al.
LANCET (2021)
SARS-CoV-2 infection rates of antibody-positive compared with antibody-negative health-care workers in England: a large, multicentre, prospective cohort study (SIREN)
Victoria Jane Hall et al.
LANCET (2021)
An update: the emerging evidence of complement involvement in COVID-19
Qin Li et al.
MEDICAL MICROBIOLOGY AND IMMUNOLOGY (2021)
Sensitivity of infectious SARS-CoV-2 B.1.1.7 and B.1.351 variants to neutralizing antibodies
Delphine Planas et al.
NATURE MEDICINE (2021)
Neutralizing antibody levels are highly predictive of immune protection from symptomatic SARS-CoV-2 infection
David S. Khoury et al.
NATURE MEDICINE (2021)
Antibody responses to the BNT162b2 mRNA vaccine in individuals previously infected with SARS-CoV-2
Joseph E. Ebinger et al.
NATURE MEDICINE (2021)
Effectiveness of the BNT162b2 Covid-19 Vaccine against the B.1.1.7 and B.1.351 Variants
Laith J. Abu-Raddad et al.
NEW ENGLAND JOURNAL OF MEDICINE (2021)
SARS-CoV-2 Antibody Response in Persons with Past Natural Infection
Gabriele Anichini et al.
NEW ENGLAND JOURNAL OF MEDICINE (2021)
A SARS-CoV-2 antibody curbs viral nucleocapsid protein-induced complement hyperactivation
Sisi Kang et al.
NATURE COMMUNICATIONS (2021)
Persistence of Neutralizing Antibody Response up to 1 Year After Asymptomatic or Symptomatic SARS-CoV-2 Infection
Pyoeng Gyun Choe et al.
JOURNAL OF INFECTIOUS DISEASES (2021)
COVID-19 optimal vaccination policies: A modeling study on efficacy, natural and vaccine-induced immunity responses
Manuel Adrian Acuna-Zegarra et al.
MATHEMATICAL BIOSCIENCES (2021)
Fc-engineered antibody therapeutics with improved anti-SARS-CoV-2 efficacy
Rachel Yamin et al.
NATURE (2021)
SARS-CoV-2 variants of concern are emerging in India
Jasdeep Singh et al.
NATURE MEDICINE (2021)
Protective humoral and cellular immune responses to SARS-CoV-2 persist up to 1 year after recovery
Chengqian Feng et al.
NATURE COMMUNICATIONS (2021)
Declining Levels of Neutralizing Antibodies Against SARS-CoV-2 in Convalescent COVID-19 Patients One Year Post Symptom Onset
Tiandan Xiang et al.
FRONTIERS IN IMMUNOLOGY (2021)
Reduced Risk of Reinfection with SARS-CoV-2 After COVID-19 Vaccination — Kentucky, May–June 2021
Alyson M. Cavanaugh et al.
MMWR-MORBIDITY AND MORTALITY WEEKLY REPORT (2021)
Severe Acute Respiratory Syndrome Coronavirus 2 P.2 Lineage Associated with Reinfection Case, Brazil, June October 2020
Paola Cristina Resende et al.
EMERGING INFECTIOUS DISEASES (2021)
Clinical Characteristics and Outcomes of COVID-19 Cohort Patients in Daegu Metropolitan City Outbreak in 2020
Shin-Woo Kim et al.
JOURNAL OF KOREAN MEDICAL SCIENCE (2021)
Characteristics of and Important Lessons From the Coronavirus Disease 2019 (COVID-19) Outbreak in China Summary of a Report of 72 314 Cases From the Chinese Center for Disease Control and Prevention
Zunyou Wu et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2020)
Cryo-EM structure of the 2019-nCoV spike in the prefusion conformation
Daniel Wrapp et al.
SCIENCE (2020)
Targets of T Cell Responses to SARS-CoV-2 Coronavirus in Humans with COVID-19 Disease and Unexposed Individuals
Alba Grifoni et al.
CELL (2020)
Aberrant hyperactivation of cytotoxic T-cell as a potential determinant of COVID-19 severity
Chang Kyung Kang et al.
INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES (2020)
Cell-Mediated Immunogenicity of Influenza Vaccination in Patients With Cancer Receiving Immune Checkpoint Inhibitors
Chang Kyung Kang et al.
JOURNAL OF INFECTIOUS DISEASES (2020)
SARS-CoV-2 neutralizing antibody levels are correlated with severity of COVID-19 pneumonia
Wei Chen et al.
BIOMEDICINE & PHARMACOTHERAPY (2020)
Tracking Changes in SARS-CoV-2 Spike: Evidence that D614G Increases Infectivity of the COVID-19 Virus
Bette Korber et al.
CELL (2020)
Viral dynamics in mild and severe cases of COVID-19
Yang Liu et al.
LANCET INFECTIOUS DISEASES (2020)
Loss of Bcl-6-Expressing T Follicular Helper Cells and Germinal Centers in COVID-19
Naoki Kaneko et al.
CELL (2020)
Complement and tissue factor-enriched neutrophil extracellular traps are key drivers in COVID-19 immunothrombosis
Panagiotis Skendros et al.
JOURNAL OF CLINICAL INVESTIGATION (2020)
Systemic complement activation is associated with respiratory failure in COVID-19 hospitalized patients
Jan C. Holter et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2020)
Antibody Responses to SARS-CoV-2 at 8 Weeks Postinfection in Asymptomatic Patients
Pyoeng Gyun Choe et al.
EMERGING INFECTIOUS DISEASES (2020)
Kinetics of SARS-CoV-2 specific IgM and IgG responses in COVID-19 patients
Baoqing Sun et al.
EMERGING MICROBES & INFECTIONS (2020)
A Sample-Sparing Multiplexed ADCP Assay
Audrey L. Butler et al.
FRONTIERS IN IMMUNOLOGY (2019)
Antibody-Dependent Cellular Phagocytosis in Antiviral Immune Responses
Matthew Zirui Tay et al.
FRONTIERS IN IMMUNOLOGY (2019)
An Engineered Human Fc variant With Exquisite Selectivity for FcγRIIIaV158 Reveals That Ligation of FcγRIIIa Mediates Potent Antibody Dependent Cellular Phagocytosis With GM-CSF-Differentiated Macrophages
Tae Hyun Kang et al.
FRONTIERS IN IMMUNOLOGY (2019)
IgG Fc domains that bind C1q but not effector Fcγ receptors delineate the importance of complement-mediated effector functions
Chang-Han Lee et al.
NATURE IMMUNOLOGY (2017)
Altered IL-7Rα expression with aging and the potential implications of IL-7 therapy on CD8+ T-cell immune responses
HR Kim et al.
BLOOD (2006)
Fc receptor-mediated phagocytosis makes a significant contribution to clearance of influenza virus infections
VC Huber et al.
JOURNAL OF IMMUNOLOGY (2001)